SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000947871-22-000125
Filing Date
2022-02-01
Accepted
2022-02-01 17:09:01
Documents
1
Period of Report
2022-02-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5145
  Complete submission text file 0000947871-22-000125.txt   6639
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Issuer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address #30, "GALAXY," 1ST MAIN J.P. NAGAR 3RD PHASE BANGALORE K7 560078
Business Address
Pillai Arun Kumar (Reporting) CIK: 0001717437 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37759 | Film No.: 22580044